2 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Withdrawn 2 |
Follow Hyponatremia: new trials by email Literature Review of Hyponatremia trials Research Report on Hyponatremia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia Tolvaptan, Placebo - Hyponatremia | Phase 3 | Withdrawn | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2015-11-01 | 2017-07-31 | |
| Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients Conivaptan, D5 - Hyponatremia | Phase 3 | Withdrawn | Columbia University | 2008-05-01 | 2015-03-06 |
Metabolic Diseases (1) · Trauma, Nervous System (1) · Water-Electrolyte Imbalance (1)
Nutritional and Metabolic Diseases (2) · Metabolic Diseases (1) · Nervous System Diseases (1) · Water-Electrolyte Imbalance (1) · Wounds and Injuries (1)
Tolvaptan (1) · conivaptan (1)
Columbia University (1) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1)
United States (1)
Ann Dandurand, MD (1) · Stephan A. Mayer, MD (1)